Fei Luo

4.9k total citations
135 papers, 3.8k citations indexed

About

Fei Luo is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Fei Luo has authored 135 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 29 papers in Cancer Research and 24 papers in Biomedical Engineering. Recurrent topics in Fei Luo's work include Bone Tissue Engineering Materials (24 papers), Bone Metabolism and Diseases (22 papers) and MicroRNA in disease regulation (21 papers). Fei Luo is often cited by papers focused on Bone Tissue Engineering Materials (24 papers), Bone Metabolism and Diseases (22 papers) and MicroRNA in disease regulation (21 papers). Fei Luo collaborates with scholars based in China, United States and South Korea. Fei Luo's co-authors include Jianzhong Xu, Tianyong Hou, Ce Dou, Shiwu Dong, Qizhan Liu, Zhao Xie, Hui Xu, Junchao Xue, Xinlu Liu and Ning Ding and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Fei Luo

129 papers receiving 3.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Fei Luo 2.2k 1.2k 538 494 477 135 3.8k
Jeong‐Hwa Baek 1.9k 0.9× 574 0.5× 335 0.6× 616 1.2× 720 1.5× 133 3.8k
Yue Wang 3.2k 1.4× 2.2k 1.8× 417 0.8× 231 0.5× 290 0.6× 111 4.9k
Li Liao 1.9k 0.9× 869 0.7× 429 0.8× 393 0.8× 288 0.6× 101 3.7k
Xin Fu 1.6k 0.7× 617 0.5× 628 1.2× 641 1.3× 335 0.7× 148 4.1k
Dan Zhao 1.7k 0.8× 858 0.7× 482 0.9× 289 0.6× 976 2.0× 249 4.2k
Nicholas R. Forsyth 1.5k 0.7× 576 0.5× 810 1.5× 582 1.2× 263 0.6× 102 3.8k
Jie Cheng 2.1k 0.9× 1000 0.8× 223 0.4× 239 0.5× 785 1.6× 163 3.9k
Shi‐You Chen 2.0k 0.9× 708 0.6× 469 0.9× 226 0.5× 258 0.5× 128 3.6k
Ferdinando Mannello 1.1k 0.5× 903 0.7× 798 1.5× 211 0.4× 594 1.2× 144 4.5k

Countries citing papers authored by Fei Luo

Since Specialization
Citations

This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).

Fields of papers citing papers by Fei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.

Co-authorship network of co-authors of Fei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Luo. A scholar is included among the top collaborators of Fei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Luo. Fei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Ye, Jiulin Tan, Chengmin Zhang, et al.. (2024). LL-37 and bisphosphonate co-delivery 3D-scaffold with antimicrobial and antiresorptive activities for bone regeneration. International Journal of Biological Macromolecules. 277(Pt 1). 134091–134091. 8 indexed citations
2.
Shen, Jie, et al.. (2024). Infographic: Chongqing technique. Bone and Joint Research. 13(3). 124–126. 2 indexed citations
3.
Shen, Jie, et al.. (2024). The induced membrane technique for the management of infected segmental bone defects. The Bone & Joint Journal. 106-B(6). 613–622. 1 indexed citations
4.
Wang, Xiaohua, et al.. (2024). Clinical characteristics and outcomes associated with culture-negative status in limb osteomyelitis patients. The Bone & Joint Journal. 106-B(7). 720–727.
5.
Wu, Yutong, Yuhang Xi, Pengbin Yin, et al.. (2023). Reduced osteoclast-derived apoptotic bodies in bone marrow characterizes the pathological progression of osteoporosis. Cell Death Discovery. 9(1). 135–135. 5 indexed citations
6.
Sun, Dong, Shulin Wang, Jie Shen, et al.. (2023). Incidence and risk factors of recurrence in limb osteomyelitis patients after antibiotic‐loaded cement spacer for definitive bone defect treatment. Bone and Joint Research. 12(8). 467–475. 7 indexed citations
8.
Luo, Keyu, Jiulin Tan, Rui Zhou, et al.. (2021). Laminin alpha 4 promotes bone regeneration by facilitating cell adhesion and vascularization. Acta Biomaterialia. 126. 183–198. 24 indexed citations
9.
Luo, Fei, et al.. (2020). Lamin B1 Promotes Tumor Progression and Metastasis in Primary Prostate Cancer Patients. Future Oncology. 17(6). 663–673. 13 indexed citations
10.
Luo, Keyu, Xiaoliang Gao, Yuan Gao, et al.. (2018). Multiple integrin ligands provide a highly adhesive and osteoinductive surface that improves selective cell retention technology. Acta Biomaterialia. 85. 106–116. 21 indexed citations
11.
Deng, Moyuan, Keyu Luo, Tianyong Hou, et al.. (2017). IGFBP3 deposited in the human umbilical cord mesenchymal stem cell‐secreted extracellular matrix promotes bone formation. Journal of Cellular Physiology. 233(8). 5792–5804. 24 indexed citations
12.
Luo, Keyu, Zhiqiang Li, Moyuan Deng, et al.. (2016). A High-Adhesive Lysine-Cyclic RGD Peptide Designed for Selective Cell Retention Technology. Tissue Engineering Part C Methods. 22(6). 585–595. 12 indexed citations
13.
Li, Zhiqiang, Tianyong Hou, Moyuan Deng, et al.. (2014). The Osteogenetic Efficacy of Goat Bone Marrow-Enriched Self-Assembly Peptide/Demineralized Bone Matrix In Vitro and In Vivo. Tissue Engineering Part A. 21(7-8). 1398–1408. 7 indexed citations
14.
Chang, Zhengqi, Tianyong Hou, Xuehui Wu, et al.. (2013). An Anti-Infection Tissue-Engineered Construct Delivering Vancomycin: its Evaluation in a Goat Model of Femur Defect. International Journal of Medical Sciences. 10(12). 1761–1770. 9 indexed citations
15.
Wu, Xuehui, Tianyong Hou, Fei Luo, et al.. (2013). Vascular Endothelial Growth Factor and Physiological Compressive Loading Synergistically Promote Bone Formation of Tissue-Engineered Bone. Tissue Engineering Part A. 19(21-22). 2486–2494. 9 indexed citations
16.
Xing, Junchao, et al.. (2012). Anti-Infection Tissue Engineering Construct Treating Osteomyelitis in Rabbit Tibia. Tissue Engineering Part A. 19(1-2). 255–263. 27 indexed citations
17.
Hou, Tianyong, Jianzhong Xu, Xuehui Wu, et al.. (2009). Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering. Tissue Engineering Part A. 15(9). 2325–2334. 73 indexed citations
18.
Hou, Tianyong, Qiang Li, Fei Luo, et al.. (2009). Controlled Dynamization to Enhance Reconstruction Capacity of Tissue-Engineered Bone in Healing Critically Sized Bone Defects: An In Vivo Study in Goats. Tissue Engineering Part A. 16(1). 201–212. 21 indexed citations
19.
Chu, Deyong, Fei Luo, Meijuan Zheng, et al.. (2008). [Effect of paeoniflorin on secretion of TGF-beta1 from macrophages in mice].. PubMed. 26(2). 81–5. 3 indexed citations
20.
Luo, Qingli, et al.. (2007). Application of indirect ELISA with recombinant signaling protein 14-3-3 of Schistosoma japonicum for the immunodiagnosis of schistosomiasis. Zhongguo renshougonghuanbing zazhi. 231–235.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026